Mycophenolate mofetil therapy in frequently relapsing steroid-dependent and steroid-resistant nephrotic syndrome of childhood: current status and future directions (Q43604565)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Mycophenolate mofetil therapy in frequently relapsing steroid-dependent and steroid-resistant nephrotic syndrome of childhood: current status and future directions	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

25 November 2017

1 reference

Europe PubMed Central

Mycophenolate mofetil therapy in frequently relapsing steroid-dependent and steroid-resistant nephrotic syndrome of childhood: current status and future directions (English)

1 reference

Europe PubMed Central

25 November 2017

nephrotic syndrome

1 reference

based on heuristic

inferred from title

Stanley C Jordan

3

object named as

Stanley C Jordan

1 reference

Europe PubMed Central

25 November 2017

author name string

Asha Moudgil

1

1 reference

Europe PubMed Central

25 November 2017

Arvind Bagga

2

1 reference

Europe PubMed Central

25 November 2017

publication date

24 June 2005

1 reference

Europe PubMed Central

25 November 2017

Pediatric Nephrology

1 reference

Europe PubMed Central

25 November 2017

20

1 reference

Europe PubMed Central

25 November 2017

10

1 reference

Europe PubMed Central

25 November 2017

1376-1381

1 reference

Europe PubMed Central

25 November 2017

https://scigraph.springernature.com/pub.10.1007/s00467-005-1964-z

0 references

Persistent proteinuria up-regulates angiotensin II type 2 receptor and induces apoptosis in proximal tubular cells

1 reference

https://api.crossref.org/works/10.1007%2FS00467-005-1964-Z

21 January 2018

Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration

1 reference

https://api.crossref.org/works/10.1007%2FS00467-005-1964-Z

21 January 2018

Angiotensin antagonists and steroids in the treatment of focal segmental glomerulosclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enalapril and prednisone in children with nephrotic-range proteinuria

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized study of two long-course prednisolone regimens for nephrotic syndrome in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The primary nephrotic syndrome of childhood. Classification and clinicopathologic study of 406 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel therapy of focal glomerulosclerosis with mycophenolate and angiotensin blockade

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacodynamics of immunosuppression by mycophenolic acid: inhibition of both lymphocyte proliferation and activation correlates with pharmacokinetics.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sequential therapies for proliferative lupus nephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mycophenolic acid binding to human serum albumin: characterization and relation to pharmacodynamics

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Frequently relapsing nephrotic syndrome: treatment with mycophenolate mofetil

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of idiopathic nephrotic syndrome with levamisole

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Remission of relapsing childhood nephrotic syndrome with mycophenolate mofetil

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of long-term azathioprine for relapsing nephrotic syndrome.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of cyclosporin and chlorambucil in the treatment of steroid-dependent idiopathic nephrotic syndrome: a multicentre randomized controlled trial. The French Society of Paediatric Nephrology

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Controlled trial of azathioprine in treatment of steroid-responsive nephrotic syndrome of childhood

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pulse cyclophosphamide for steroid-resistant focal segmental glomerulosclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Levamisole therapy in corticosteroid-dependent nephrotic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Age and ethnicity affect the risk and outcome of focal segmental glomerulosclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensive pulse therapies for focal glomerulosclerosis in South African children

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased incidence of insulin-dependent diabetes mellitus in pediatric renal transplant patients receiving tacrolimus (FK506)

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disseminated autoimmune disease during levamisole treatment of nephrotic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pharmacokinetic-pharmacodynamic relationship for total and free mycophenolic Acid in pediatric renal transplant recipients: a report of the german study group on mycophenolate mofetil therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucocorticoids interfere with mycophenolate mofetil bioavailability in kidney transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tacrolimus treatment for steroid- and cyclosporin-resistant minimal-change nephrotic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mycophenolic Acid Pharmacodynamics and Pharmacokinetics Provide a Basis for Rational Monitoring Strategies

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical observations of mycophenolate mofetil therapy in refractory primary nephrotic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methylprednisolone treatment of patients with steroid-resistant nephrotic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous pulse cyclophosphamide--a new regime for steroid-resistant minimal change nephrotic syndrome.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pulse cyclophosphamide inadequately suppresses reoccurrence of minimal change nephrotic syndrome in corticoid-dependent children.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous cyclophosphamide in steroid-resistant nephrotic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of focal glomerulosclerosis with pulse steroids and oral cyclophosphamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pilot trial of FK 506 in the management of steroid-resistant nephrotic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of steroid-resistant focal segmental glomerulosclerosis with pulse methylprednisolone and alkylating agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combining an antiproteinuric approach with mycophenolate mofetil fully suppresses progressive nephropathy of experimental animals

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunosuppressive therapy in high-risk transplant patients: dose-dependent efficacy of mycophenolate mofetil in African-American renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Switch from cyclosporine A to mycophenolate mofetil in nephrotic children

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful treatment of steroid-resistant minimal change disease with mycophenolate mofetil

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mycophenolic acid suppresses protein N-linked glycosylation in human monocytes and their adhesion to endothelial cells and to some substrates

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Levamisole for corticosteroid-dependent nephrotic syndrome in childhood. British Association for Paediatric Nephrology

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous methylprednisolone and oral alkylating agent therapy of prednisone-resistant pediatric focal segmental glomerulosclerosis: a long-term follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide in steroid-sensitive nephrotic syndrome: outcome and outlook

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Racial differences in the incidence and renal outcome of idiopathic focal segmental glomerulosclerosis in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mycophenolate mofetil treatment for primary glomerular diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Two-year cyclosporin treatment in children with steroid-dependent nephrotic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of nephrotic syndrome in children and controlled trials.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft für Pädiatrische Nephrologie

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunosuppressive agents in childhood nephrotic syndrome: a meta-analysis of randomized controlled trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mycophenolate mofetil in the treatment of resistant idiopathic nephrotic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of childhood prednisone-resistant nephrotic syndrome and focal segmental glomerulosclerosis with intravenous methylprednisolone and oral alkylating agents.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fertility after treatment for Hodgkin's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/15977023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00467-005-1964-Z

1 reference

Europe PubMed Central

25 November 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43604565&oldid=2101849586"